Zicix (OTCMKTS:ZICX) & Aclarion (NASDAQ:ACON) Head to Head Comparison

Aclarion (NASDAQ:ACON) and Zicix (OTCMKTS:ZICX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends.

Institutional and Insider Ownership

7.5% of Aclarion shares are held by institutional investors. 1.5% of Aclarion shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Aclarion and Zicix’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aclarion	-12,845.05%	-422.87%	-201.15%
Zicix	N/A	N/A	N/A

Risk and Volatility

Aclarion has a beta of 0.47, suggesting that its stock price is 53% less volatile than the S&P 500. Comparatively, Zicix has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500.

Valuation and Earnings

This table compares Aclarion and Zicix”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aclarion	$80,000.00	10.82	-$4.91 million	N/A	N/A
Zicix	N/A	N/A	N/A	N/A	N/A

Zicix has lower revenue, but higher earnings than Aclarion.

Analyst Ratings

This is a summary of current ratings and recommmendations for Aclarion and Zicix, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aclarion	0	1	1	0	2.50
Zicix	0	0	0	0	0.00

Aclarion presently has a consensus target price of $1.30, suggesting a potential upside of 2,267.94%. Given Aclarion’s stronger consensus rating and higher probable upside, research analysts plainly believe Aclarion is more favorable than Zicix.

Summary

Aclarion beats Zicix on 6 of the 10 factors compared between the two stocks.

About Aclarion

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

About Zicix

Zicix Corporation, through its subsidiary, Texas Mobile Health, Inc., provides diagnostic medical imaging services in Houston, Texas. It offers cardiac diagnostic services, including echocardiogram, stress testing, carotid ultrasound, and halter and event monitoring services; medical services, such as general medical care, medical care for home health patients, general and immigration physicals, weight reduction, cold laser pain relief treatment, physical therapy, and anti-aging treatment; and MRI, CT, and X-Ray services. The company was formerly known as Bederra Corporation and changed its name to Zicix Corporation on February 8, 2011. Zicix Corporation was founded in 1979 and is based in Houston, Texas.